Biofrontera Inc. (BFRIW)
NASDAQ: BFRIW · Real-Time Price · USD · Warrants
0.0221
0.00 (0.00%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Company Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.
The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Biofrontera Inc.
| Country | United States |
| Founded | 2015 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 89 |
| CEO | Hermann Luebbert |
Contact Details
Address: 660 Main Street, 1st Floor Woburn, Massachusetts 01801 United States | |
| Phone | 781 245 1325 |
| Website | biofrontera-us.com |
Stock Details
| Ticker Symbol | BFRIW |
| Exchange | NASDAQ |
| Stock Type | Warrants |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001858685 |
| CUSIP Number | 09077D118 |
| ISIN Number | US09077D1182 |
Key Executives
| Name | Position |
|---|---|
| Dr. Hermann Luebbert Ph.D. | Chief Executive Officer, President and Chairman |
| Eugene Frederick Leffler III | Chief Financial Officer |
| George P. Jones | Chief Commercial Officer |
| Erica F. Gates CPA, M.B.A. | Vice President of Finance and Principal Accounting Officer |
| Jon Lyons M.B.A., Ph.D. | Vice President of Scientific and Medical Affairs |
| Daniel Hakansson J.D. | Senior Corporate Counsel |
| Samantha Widdicombe | Senior Vice President of Sales and Strategic Accounts |